Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials

Originalsprog	Engelsk
Status	Afsendt - 2022

Priser

• Finalist for Knowledge and Innovation IG Best PhD Paper Prize

  Balasubramanian, Parasuram (Modtager), 2019

  Pris: Konferencepriser

Citationsformater

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Balasubramanian, P., Pierce, L., & Cummings, T. (2022). Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials.

Balasubramanian, Parasuram ; Pierce, Lamar ; Cummings, Trey. / Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials. 2022.

@techreport{05f7af6ba46c4704b12b7450af949265,

title = "Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials",

author = "Parasuram Balasubramanian and Lamar Pierce and Trey Cummings",

year = "2022",

language = "English",

type = "WorkingPaper",

}

Balasubramanian, P, Pierce, L & Cummings, T 2022 'Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials'.

Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials. / Balasubramanian, Parasuram; Pierce, Lamar; Cummings, Trey.
2022.

Publikation: Working paper/Preprint › Working paper › Forskning › peer review

TY - UNPB

T1 - Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials

AU - Balasubramanian, Parasuram

AU - Pierce, Lamar

AU - Cummings, Trey

PY - 2022

Y1 - 2022

M3 - Working paper

BT - Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials

ER -

Balasubramanian P, Pierce L, Cummings T. Research Validity Across Organizational Forms: Evidence from Phase 2 Oncology Clinical Trials. 2022.